State Street’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-168,881
| Closed | -$62.5K | – | 4347 |
|
|
2025
Q1 | $62.5K | Hold |
168,881
| – | – | ﹤0.01% | 4058 |
|
|
2024
Q4 | $121K | Buy |
168,881
+14,742
| +10% | +$15.3K | ﹤0.01% | 3956 |
|
|
2024
Q3 | $173K | Hold |
154,139
| – | – | ﹤0.01% | 3853 |
|
|
2024
Q2 | $168K | Hold |
154,139
| – | – | ﹤0.01% | 3868 |
|
|
2024
Q1 | $196K | Sell |
154,139
-12,900
| -8% | -$17K | ﹤0.01% | 3878 |
|
|
2023
Q4 | $232K | Hold |
167,039
| – | – | ﹤0.01% | 3866 |
|
|
2023
Q3 | $234K | Hold |
167,039
| – | – | ﹤0.01% | 3892 |
|
|
2023
Q2 | $307K | Sell |
167,039
-17,100
| -9% | -$39.6K | ﹤0.01% | 3863 |
|
|
2023
Q1 | $447K | Hold |
184,139
| – | – | ﹤0.01% | 3774 |
|
|
2022
Q4 | $263K | Sell |
184,139
-1,500
| -0.8% | -$2.92K | ﹤0.01% | 4006 |
|
|
2022
Q3 | $414K | Hold |
185,639
| – | – | ﹤0.01% | 3853 |
|
|
2022
Q2 | $384K | Sell |
185,639
-12,494
| -6% | -$30.9K | ﹤0.01% | 3944 |
|
|
2022
Q1 | $575K | Buy |
198,133
+2,779
| +1% | +$8.92K | ﹤0.01% | 3985 |
|
|
2021
Q4 | $627K | Hold |
195,354
| – | – | ﹤0.01% | 3938 |
|
|
2021
Q3 | $692K | Hold |
195,354
| – | – | ﹤0.01% | 3878 |
|
|
2021
Q2 | $619K | Sell |
195,354
-602,964
| -76% | -$1.9M | ﹤0.01% | 3783 |
|
|
2021
Q1 | $2.75M | Sell |
798,318
-49,228
| -6% | -$153K | ﹤0.01% | 3308 |
|
|
2020
Q4 | $2.14M | Buy |
847,546
+38,163
| +5% | +$83.1K | ﹤0.01% | 3345 |
|
|
2020
Q3 | $1.71M | Buy |
809,383
+3,311
| +0.4% | +$7.87K | ﹤0.01% | 3260 |
|
|
2020
Q2 | $1.81M | Buy |
806,072
+47,440
| +6% | +$122K | ﹤0.01% | 3219 |
|
|
2020
Q1 | $1.92M | Sell |
758,632
-37,520
| -5% | -$92.2K | ﹤0.01% | 3081 |
|
|
2019
Q4 | $2.09M | Buy |
796,152
+16,733
| +2% | +$50K | ﹤0.01% | 3232 |
|
|
2019
Q3 | $2.81M | Buy |
779,419
+7,326
| +0.9% | +$25.9K | ﹤0.01% | 3089 |
|
|
2019
Q2 | $2.6M | Buy |
772,093
+29,649
| +4% | +$104K | ﹤0.01% | 3135 |
|
|
2019
Q1 | $2.03M | Buy |
742,444
+12,369
| +2% | +$40.5K | ﹤0.01% | 3142 |
|
|
2018
Q4 | $2.03M | Sell |
730,075
-30,665
| -4% | -$100K | ﹤0.01% | 3113 |
|
|
2018
Q3 | $3.13M | Buy |
760,740
+22,038
| +3% | +$100K | ﹤0.01% | 3078 |
|
|
2018
Q2 | $3.83M | Buy |
738,702
+19,359
| +3% | +$118K | ﹤0.01% | 2991 |
|
|
2018
Q1 | $3.94M | Sell |
719,343
-794
| -0.1% | -$5.59K | ﹤0.01% | 2906 |
|
|
2017
Q4 | $5.87M | Buy |
720,137
+40,823
| +6% | +$390K | ﹤0.01% | 2715 |
|
|
2017
Q3 | $7.11M | Buy |
679,314
+11,779
| +2% | +$131K | ﹤0.01% | 2609 |
|
|
2017
Q2 | $7.37M | Buy |
667,535
+84,043
| +14% | +$783K | ﹤0.01% | 2543 |
|
|
2017
Q1 | $4.88M | Buy |
583,492
+16,422
| +3% | +$116K | ﹤0.01% | 2704 |
|
|
2016
Q4 | $3.93M | Buy |
567,070
+38,672
| +7% | +$247K | ﹤0.01% | 2820 |
|
|
2016
Q3 | $2.69M | Buy |
528,398
+34,182
| +7% | +$204K | ﹤0.01% | 2853 |
|
|
2016
Q2 | $2.95M | Buy |
494,216
+472,336
| +2,159% | +$2.62M | ﹤0.01% | 2883 |
|
|
2016
Q1 | $99K | Hold |
21,880
| – | – | ﹤0.01% | 3559 |
|
|
2015
Q4 | $99K | Buy |
21,880
+600
| +3% | +$2.53K | ﹤0.01% | 3552 |
|
|
2015
Q3 | $67K | Hold |
21,280
| – | – | ﹤0.01% | 3562 |
|
|
2015
Q2 | $64K | Sell |
21,280
-401,000
| -95% | -$1.13M | ﹤0.01% | 3566 |
|
|
2015
Q1 | $1.25M | Buy |
422,280
+70,471
| +20% | +$231K | ﹤0.01% | 3177 |
|
|
2014
Q4 | $1.56M | Buy |
351,809
+12,037
| +4% | +$57.4K | ﹤0.01% | 3139 |
|
|
2014
Q3 | $1.75M | Buy |
339,772
+12,918
| +4% | +$68.9K | ﹤0.01% | 3073 |
|
|
2014
Q2 | $1.72M | Buy |
326,854
+303,274
| +1,286% | +$1.31M | ﹤0.01% | 3116 |
|
|
2014
Q1 | $97K | Hold |
23,580
| – | – | ﹤0.01% | 3505 |
|
|
2013
Q4 | $69K | Hold |
23,580
| – | – | ﹤0.01% | 3515 |
|
|
2013
Q3 | $60K | Sell |
23,580
-14
| -0.1% | -$33 | ﹤0.01% | 3507 |
|
|
2013
Q2 | $49K | Buy |
+23,594
| New | +$52.1K | ﹤0.01% | 3447 |
|
Other funds holding ENZ
RC
XT
KCM
GSC
State Street's ENZ Position: Q2 2025 in Review
State Street sold out of Enzo Biochem, Inc. (ENZ) in Q2 2025, closing a stake of 168,881 shares — an estimated $62.5K sold.
State Street first reported a position in ENZ in Q2 2013 and held it in 48 quarters. The position peaked at $7.37M in Q2 2017. 6 funds tracked by Wall St. Rank hold ENZ as of Q2 2025.
- State Street reported no remaining Enzo Biochem, Inc. position as of Q2 2025 after selling out during the quarter.
- State Street sold 168,881 Enzo Biochem, Inc. shares in Q2 2025, an estimated $62.5K.
- State Street first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 48 quarters.
- State Street's Enzo Biochem, Inc. position peaked at $7.37M in Q2 2017.
- 6 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2025.
Based on State Street's 13F filing for Q2 2025, filed 14 Aug 2025.